These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7746044)

  • 41. [Genetic testing for cancer susceptibility: the present situation in Japan].
    Miki Y
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):930-7. PubMed ID: 9212800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oncogenetics saves lifes.
    Azoicăi D
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):7-10. PubMed ID: 24741768
    [No Abstract]   [Full Text] [Related]  

  • 43. Introduction of a German genetic counseling program for hereditary breast and ovarian cancer.
    Maass N
    Jpn J Clin Oncol; 1999 Apr; 29(4):234-6. PubMed ID: 10340050
    [No Abstract]   [Full Text] [Related]  

  • 44. [Molecular diagnostics in oncology].
    Imianitov EN
    Vopr Onkol; 2012; 58(2):153-63. PubMed ID: 22774518
    [No Abstract]   [Full Text] [Related]  

  • 45. Genetics and prevention: a policy in the making.
    Svendsen MN; Koch L
    New Genet Soc; 2006 Apr; 25(1):51-68. PubMed ID: 17312630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer genetics: surveillance and control.
    Lynch HT; Lynch JF; Fusaro RM
    Compr Ther; 1987 Jun; 13(6):6-16. PubMed ID: 3581749
    [No Abstract]   [Full Text] [Related]  

  • 47. [Problem of the hereditary breast cancer screening; including the genetic diagnosis].
    Saito H; Miki Y
    Nihon Rinsho; 2012 Sep; 70 Suppl 7():480-6. PubMed ID: 23350446
    [No Abstract]   [Full Text] [Related]  

  • 48. The Japanese Breast Cancer Society clinical practice guideline for epidemiology and prevention of breast cancer.
    Taira N; Arai M; Ikeda M; Iwasaki M; Okamura H; Takamatsu K; Yamamoto S; Ohsumi S; Mukai H;
    Breast Cancer; 2015 Jan; 22(1):16-27. PubMed ID: 25085807
    [No Abstract]   [Full Text] [Related]  

  • 49. Risky communication: pitfalls in counseling about risk, and how to avoid them.
    O'Doherty K; Suthers GK
    J Genet Couns; 2007 Aug; 16(4):409-17. PubMed ID: 17473963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of population-based studies in assessing genetic cancer risk.
    Berry DA
    J Natl Cancer Inst; 2001 Aug; 93(16):1188-9. PubMed ID: 11504754
    [No Abstract]   [Full Text] [Related]  

  • 51. Cancer genetics, genetic counseling, and cancer control.
    Lynch HT; Lynch JF
    Nebr Med J; 1975 Feb; 60(2):33-7. PubMed ID: 1134602
    [No Abstract]   [Full Text] [Related]  

  • 52. Screening of patients at high risk for cancer.
    O'Bryan RM
    Henry Ford Hosp Med J; 1984; 32(1):5-11. PubMed ID: 6746302
    [No Abstract]   [Full Text] [Related]  

  • 53. Studying the connection between exercise and cancer risk reduction.
    O'Hanlon LH
    J Natl Cancer Inst; 2013 Jun; 105(11):753-4. PubMed ID: 23682132
    [No Abstract]   [Full Text] [Related]  

  • 54. [Oral mucous membrane epithelium sex chromatin in patients with malignant neoplasms].
    Voĭtenko VP
    Vopr Onkol; 1973; 19(9):11-5. PubMed ID: 4788391
    [No Abstract]   [Full Text] [Related]  

  • 55. Testing for a troublesome gene.
    Titus K
    CAP Today; 1996 Apr; 10(4):14-6, 18, 20 passim. PubMed ID: 10160265
    [No Abstract]   [Full Text] [Related]  

  • 56. Genetic risk information for common diseases may indeed be already useful for prevention and early detection.
    Gulcher J; Stefansson K
    Eur J Clin Invest; 2010 Jan; 40(1):56-63. PubMed ID: 20055896
    [No Abstract]   [Full Text] [Related]  

  • 57. Genetic predisposition to cancer.
    Cannon-Albright LA; Bishop DT; Goldgar C; Skolnick MH
    Important Adv Oncol; 1991; ():39-55. PubMed ID: 1869281
    [No Abstract]   [Full Text] [Related]  

  • 58. Genetic counselling and hereditary breast ovarian cancer.
    Lynch HT; Watson P
    Lancet; 1992 May; 339(8802):1181. PubMed ID: 1349410
    [No Abstract]   [Full Text] [Related]  

  • 59. Genetic counselling for familial breast and ovarian cancer in Ontario.
    Andermann A; Narod SA
    J Med Genet; 2002 Sep; 39(9):695-6. PubMed ID: 12205116
    [No Abstract]   [Full Text] [Related]  

  • 60. A methodology for cancer control utilizing Cancer Information Service data.
    Eckert D
    Prog Clin Biol Res; 1983; 130():161-70. PubMed ID: 6622451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.